The FTC affirmed a 2006 US District Court for the District of New Jersey ruling that RTC Research & Development (RTC) was guilty of “false and unsubstantiated advertising” of the weight loss product, Xenadrine EFX.
Much of the offending material was in the form of testimonials and comes at a time when the FTC is mulling over potential amendments to the laws that govern such marketing so that companies may find it more difficult to employ them.
The ruling
The 2006 ruling stated RTC, along with its owners, Tracy Chinery, and her husband Robert Chinery, Jr, who were also defendants in the case, had to pay $8m to compensate deceived consumers and to limit future advertising claims.
Xenadrine EFX was marketed as being clinically proven to cause rapid and substantial weight loss and was said to be more effective than ephedrine-based diet products that were banned by the Food and Drug Administration (FDA) in 2004.
Yours in Health,
Lee Labrada
Your Lean Body Coach™
Houston, Texas